These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35484598)

  • 1. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis.
    Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F
    Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer.
    Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S
    Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A growth factor-reduced culture system for colorectal cancer organoids.
    Tan R; Zhang Z; Ding P; Liu Y; Liu H; Lu M; Chen YG
    Cancer Lett; 2024 Apr; 588():216737. PubMed ID: 38382667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
    Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
    Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer.
    Norkin M; Ordóñez-Morán P; Huelsken J
    Cell Rep; 2021 Apr; 35(3):109026. PubMed ID: 33882314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel-based colorectal cancer organoid co-culture models.
    Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
    Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model.
    Atanasova VS; de Jesus Cardona C; Hejret V; Tiefenbacher A; Mair T; Tran L; Pfneissl J; Draganić K; Binder C; Kabiljo J; Clement J; Woeran K; Neudert B; Wohlhaupter S; Haase A; Domazet S; Hengstschläger M; Mitterhauser M; Müllauer L; Tichý B; Bergmann M; Schweikert G; Hartl M; Dolznig H; Egger G
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1391-1419. PubMed ID: 36868311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA methylation landscape of human cancer organoids available at the American type culture collection.
    Joshi R; Castro De Moura M; Piñeyro D; Alvarez-Errico D; Arribas C; Esteller M
    Epigenetics; 2020 Nov; 15(11):1167-1177. PubMed ID: 32396494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling colorectal cancer: A bio-resource of 50 patient-derived organoid lines.
    Engel RM; Jardé T; Oliva K; Kerr G; Chan WH; Hlavca S; Nickless D; Archer SK; Yap R; Ranchod P; Bell S; Niap A; Koulis C; Chong A; Wilkins S; Dale TC; Hollins AJ; McMurrick PJ; Abud HE
    J Gastroenterol Hepatol; 2022 May; 37(5):898-907. PubMed ID: 35244298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer.
    Chen K; Ma Y; Zhong X; Lan J; Long D; Tian X; Yang Y; Yang Y
    Cancer Lett; 2024 Feb; 582():216586. PubMed ID: 38081505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of microRNA Profiles in Organoids Derived from Human Colorectal Adenoma and Cancer.
    Nagai H; Kuroha M; Handa T; Karasawa H; Ohnuma S; Naito T; Moroi R; Kanazawa Y; Shiga H; Hamada S; Kakuta Y; Naitoh T; Kinouchi Y; Shimosegawa T; Masamune A
    Digestion; 2021; 102(6):860-869. PubMed ID: 33647915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids.
    Mao Y; Wang W; Yang J; Zhou X; Lu Y; Gao J; Wang X; Wen L; Fu W; Tang F
    Protein Cell; 2024 Apr; 15(4):285-304. PubMed ID: 37345888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
    Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
    Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells.
    Zhao H; Yan C; Hu Y; Mu L; Huang K; Li Q; Li X; Tao D; Qin J
    Int J Oncol; 2019 Mar; 54(3):893-904. PubMed ID: 30664193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
    Schnalzger TE; de Groot MH; Zhang C; Mosa MH; Michels BE; Röder J; Darvishi T; Wels WS; Farin HF
    EMBO J; 2019 Jun; 38(12):. PubMed ID: 31036555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN.
    Codrich M; Dalla E; Mio C; Antoniali G; Malfatti MC; Marzinotto S; Pierobon M; Baldelli E; Di Loreto C; Damante G; Terrosu G; Pucillo CEM; Tell G
    J Exp Clin Cancer Res; 2021 Jun; 40(1):198. PubMed ID: 34154611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.